Be Part of the Cure: Join a Paid Clinical Trial Today
We’re Here to Guide You Every Step of the Way
What Are Clinical Trials?
Clinical trials are research studies conducted on participants to determine the effectiveness and safety of investigational treatments, such as medications, surgical procedures, medical devices, new ways to use existing therapies, diagnostic tests, and even lifestyle changes.
+400K Trials
ongoing worldwide
+2M People
participate annually
+75.3%
average rate of approval for new drugs
$500 - $5000
Average compensation per clinical trial in 2023
Study Spotlight
This spotlight highlights a specific study you can join today. Learn about its purpose, that’s involved, and how you can make a meaningful impact on future healthcare
The Fatty Liver Disease Treatment Study is a clinical research trial evaluating a new oral medication designed to improve liver health in individuals with fatty liver disease. Over the course of approximately three months, participants will take the study pill for 10 days, spend one day in a monitored clinical setting, and attend follow-up visits for continued evaluation. The goal is to explore a potential therapy that could help restore liver function, improve overall health, and reduce the risks associated with fatty liver disease.
- Develop new treatment options for fatty liver disease
- Improve liver function and overall patient health
- Contribute to scientific understanding of liver disease
- Patients with fatty liver disease
- Healthcare professionals and clinical researchers
- Research institutions conducting the trial
- Potentially improved liver health and quality of life for patients
- Advancement in medical knowledge and treatment options for fatty liver disease
- Positive impact on public health in communities affected by liver conditions
More Trials
Steps to Join a Clinical Trial
With your help, we make an impact in the world.
What impact we left in the world of clinical trials
+20K
Participants Supported
+50
Clinical Trials Supported
+10
Leading Research Partners
+70
Participants Re‐enrolled in Second Study
